LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.40
-0.09 (-18.16%)
Open$0.39
Previous Close$0.49
Day High$0.51
Day Low$0.36
52W High$37.50
52W Low—
Volume—
Avg Volume176.1K
Market Cap816.4K
P/E Ratio—
EPS$-23.78
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,391.3% upside
Current
$0.40
$0.40
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 728.6K | 418.1K | 681.7K |
| Net Income | -44,377,056 | -22,922,033 | 169.3K |
| Profit Margin | -6,090.9% | -5,786.4% | 24.8% |
| EBITDA | -45,536,904 | -24,827,857 | 337.6K |
| Free Cash Flow | — | — | 110.0K |
| Rev Growth | +74.2% | +74.2% | +3.7% |
| Debt/Equity | — | — | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |